Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2026-02-03 @ 9:25 AM
Study NCT ID:
NCT01990859
Status:
COMPLETED
Last Update Posted:
2016-03-14
First Post:
2013-11-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients
Sponsor:
Bristol-Myers Squibb
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Melanoma | View |
Keywords: